Carroll E. Palmer

4.6k total citations · 1 hit paper
51 papers, 1.7k citations indexed

About

Carroll E. Palmer is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Carroll E. Palmer has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Immunology. Recurrent topics in Carroll E. Palmer's work include Tuberculosis Research and Epidemiology (26 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Mycobacterium research and diagnosis (6 papers). Carroll E. Palmer is often cited by papers focused on Tuberculosis Research and Epidemiology (26 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Mycobacterium research and diagnosis (6 papers). Carroll E. Palmer collaborates with scholars based in United States, India and United Kingdom. Carroll E. Palmer's co-authors include Lydia B. Edwards, Phyllis Q. Edwards, Francis A. Acquaviva, Verna T. Livesay, G W Comstock, J. Yerushalmy, S. Jablon, Shirley H. Ferebee, George W. Comstock and L P Ormerod and has published in prestigious journals such as JAMA, American Journal of Epidemiology and Annals of the New York Academy of Sciences.

In The Last Decade

Carroll E. Palmer

43 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States.

1969 305 citations Lydia B. Edwards, Francis A. Acquaviva et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carroll E. Palmer United States	22	1.0k	917	313	307	65	51	1.7k
Lydia B. Edwards United States	19	795 0.8×	773 0.8×	284 0.9×	212 0.7×	61 0.9×	32	1.2k
Verna T. Livesay United States	12	1.0k 1.0×	780 0.9×	426 1.4×	227 0.7×	31 0.5×	15	1.3k
R Prabhakar India	25	1.3k 1.3×	962 1.0×	852 2.7×	252 0.8×	70 1.1×	103	2.0k
J. M. Pönnighaus United Kingdom	23	1.3k 1.3×	829 0.9×	358 1.1×	390 1.3×	29 0.4×	52	1.6k
Johan N. Bruun Norway	22	1.1k 1.1×	692 0.8×	136 0.4×	356 1.2×	68 1.0×	75	2.3k
J Giron Spain	21	512 0.5×	768 0.8×	150 0.5×	229 0.7×	17 0.3×	61	1.7k
K Stýblo Netherlands	21	1.8k 1.8×	1.2k 1.4×	739 2.4×	227 0.7×	9 0.1×	72	2.2k
Peter Phillips Canada	30	1.4k 1.4×	1.5k 1.6×	295 0.9×	112 0.4×	183 2.8×	76	2.3k
Michael F. Rein United States	21	226 0.2×	910 1.0×	78 0.2×	151 0.5×	23 0.4×	43	1.6k
E Švandová Czechia	13	319 0.3×	310 0.3×	144 0.5×	90 0.3×	22 0.3×	75	779

Countries citing papers authored by Carroll E. Palmer

Since Specialization

Citations

This map shows the geographic impact of Carroll E. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carroll E. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carroll E. Palmer more than expected).

Fields of papers citing papers by Carroll E. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carroll E. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carroll E. Palmer. The network helps show where Carroll E. Palmer may publish in the future.

Co-authorship network of co-authors of Carroll E. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Carroll E. Palmer. A scholar is included among the top collaborators of Carroll E. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carroll E. Palmer. Carroll E. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Palmer, Carroll E., et al.. (2019). Studies on Prevention of Experimental Tuberculosis with Isoniazid1.

2.

Palmer, Carroll E.. (2015). Naturally Acquired Tuberculin Sensitivity in New Guinea. American Review of Respiratory Disease.

3.

Edwards, Lydia B., et al.. (1969). An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States.. PubMed. 99(4). Suppl:1–132. 305 indexed citations breakdown →

4.

Lowell, Anthony M., Lydia B. Edwards, & Carroll E. Palmer. (1969). Tuberculosis: Part I, Tuberculosis Morbidity and Mortality and Its Control. Part II, Tuberculous Infection. 1 indexed citations

5.

Edwards, Lydia B. & Carroll E. Palmer. (1968). IDENTIFICATION OF THE TUBERCULOUS‐INFECTED BY SKIN TESTS*. Annals of the New York Academy of Sciences. 154(1). 140–148. 23 indexed citations

6.

Edwards, Lydia B., George W. Comstock, & Carroll E. Palmer. (1968). Contributions of Northern Populations to the Understanding of Tuberculin Sensitivity. Archives of Environmental Health An International Journal. 17(4). 507–516. 26 indexed citations

7.

Horwitz, O & Carroll E. Palmer. (1964). EPIDEMIOLOGICAL BASIS OF TUBERCULOSIS ERADICATION. 2. DYNAMICS OF TUBERCULOSIS MORBIDITY AND MORTALITY.. PubMed. 30. 609–21. 11 indexed citations

8.

Edwards, Phyllis Q. & Carroll E. Palmer. (1964). SENSITIVITY TO HISTOPLASMIN AMONG NEGRO AND WHITE RESIDENTS OF DIFFERENT COMMUNITIES IN THE USA.. PubMed. 30. 575–85. 8 indexed citations

9.

Edwards, Phyllis Q. & Carroll E. Palmer. (1963). Nationwide Histoplasmin Sensitivity and Histoplasmal Infection. Public Health Reports (1896-1970). 78(3). 241–241. 32 indexed citations

10.

Bjérkedal, Tor & Carroll E. Palmer. (1962). EFFECT OF ISONIAZID PROPHYLAXIS IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS ACTION OF ISONTAZID IN VIVO2. American Journal of Epidemiology. 76(2). 89–123. 3 indexed citations

11.

Edwards, Lydia B., et al.. (1960). EPIDEMIOLOGIC STUDIES OF TUBERCULIN SENSITIVITY. American Journal of Epidemiology. 71(2). 218–241. 31 indexed citations

12.

Edwards, Lydia B., Phyllis Q. Edwards, & Carroll E. Palmer. (1959). Sources of Tuberculin Sensitivity in Human Populations. A Summing up of Recent Epidemiological Research.. 77–97. 20 indexed citations

13.

Palmer, Carroll E., et al.. (1959). Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity. The Journal of Pediatrics. 55(4). 413–429. 71 indexed citations

14.

Yerushalmy, J. & Carroll E. Palmer. (1959). On the methodology of investigations of etiologic factors in chronic diseases. Journal of Chronic Diseases. 10(1). 27–40. 133 indexed citations

15.

Palmer, Carroll E., et al.. (1958). Community trials of BCG vaccination.. PubMed. 77(6). 877–907. 77 indexed citations

16.

Palmer, Carroll E. & Phyllis Q. Edwards. (1958). The dose of histoplasmin H-42 for skin testing.. PubMed. 77(3). 546–50. 4 indexed citations

17.

Palmer, Carroll E., et al.. (1956). Mortality among Former Student Nurses during the Last Decade. Public Health Reports (1896-1970). 71(9). 914–914. 1 indexed citations

18.

Ferebee, Shirley H. & Carroll E. Palmer. (1956). Prevention of experimental tuberculosis with isoniazid.. PubMed. 73(1). 1–18. 25 indexed citations

19.

Ferebee, Shirley H., Larry E. Hopwood, & Carroll E. Palmer. (1956). Studies on prevention of experimental tuberculosis with isoniazid. II. Effects of different dosage regimens.. PubMed. 74(6). 917–39. 15 indexed citations

20.

Meyer, Sven & Carroll E. Palmer. (1952). BCG-vaccine studies. 5. Field studies of the significance of dead bacilli in BCG vaccine.. PubMed. 7(2). 201–29.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact